Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study
Oakes, Tina Marie Myers, Skljarevsuki, Vladimir, Zhang, Qi, Kielbasa, William, Hodsdon, Michael E, Detke, Holland C, Camporeale, Angelo, Saper, Joel RLanguage:
english
Journal:
Cephalalgia
DOI:
10.1177/0333102417747230
Date:
January, 2018
File:
PDF, 344 KB
english, 2018